Live Breaking News & Updates on Igor Astsaturov

Stay updated with breaking news from Igor astsaturov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-184 for Pancreatic Cancer at the AACR Special Conference for Pancreatic Cancer

14.09.2022 - Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ( A.I. ) and machine learning (“M.L.”) platform to transform the cost, pace, and timeline of oncology drug discovery . Seite 1 ....

Igor Astsaturov , Drug Administration , Concetta Greenberg Pancreatic Cancer Institute , Fox Chase Cancer Center , Orphan Drug Designation , Rare Pediatric , Disease Designation , Lantern Pharma ,